SciVision Biotech Inc.(TW:1786)
NT$52.00+0.90 (+10.52%)
TW:1786
SciVision Biotech Inc. financials statements
NT$52.00
At close:+0.90 (+10.52%)
SciVision Biotech Inc. (1786) Financial Statements
SciVision Biotech Inc. Financial Overview
SciVision Biotech Inc.'s market cap is currently NT$3.89B. The company's EPS TTM is NT$2.43; its P/E ratio is 21.40; and it has a dividend yield of 3.67%. SciVision Biotech Inc. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | NT$ 886.62M | NT$ 883.31M | NT$ 712.99M | NT$ 557.35M | NT$ 505.54M |
| Gross Profit | NT$ 638.39M | NT$ 655.68M | NT$ 512.49M | NT$ 371.87M | NT$ 341.84M |
| Operating Income | NT$ 189.92M | NT$ 248.11M | NT$ 199.64M | NT$ 176.23M | NT$ 124.25M |
| EBITDA | NT$ 270.35M | NT$ 362.50M | NT$ 281.35M | NT$ 238.28M | NT$ 177.27M |
| Net Income | NT$ 162.34M | NT$ 242.25M | NT$ 177.90M | NT$ 141.72M | NT$ 101.72M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | NT$ 1.05B | NT$ 871.43M | NT$ 804.06M | NT$ 673.89M | NT$ 695.84M |
| Total Assets | NT$ 2.67B | NT$ 2.35B | NT$ 2.16B | NT$ 2.10B | NT$ 2.26B |
| Total Debt | NT$ 485.13M | NT$ 224.24M | NT$ 347.91M | NT$ 416.05M | NT$ 635.37M |
| Net Debt | NT$ -360.67M | NT$ -481.79M | NT$ -163.19M | NT$ -170.97M | NT$ -23.55M |
| Total Liabilities | NT$ 689.35M | NT$ 457.43M | NT$ 533.66M | NT$ 587.30M | NT$ 812.06M |
| Stockholders' Equity | NT$ 1.98B | NT$ 1.90B | NT$ 1.63B | NT$ 1.51B | NT$ 1.45B |
| Cash Flow | |||||
| Free Cash Flow | NT$ 22.46M | NT$ 234.99M | NT$ 257.17M | NT$ 163.24M | NT$ 72.73M |
| Operating Cash Flow | NT$ 123.99M | NT$ 269.87M | NT$ 272.01M | NT$ 178.21M | NT$ 98.51M |
| Investing Cash Flow | NT$ -142.74M | NT$ 97.52M | NT$ -213.37M | NT$ 49.59M | NT$ -77.00M |
| Financing Cash Flow | NT$ 158.53M | NT$ -172.52M | NT$ -134.53M | NT$ -299.71M | NT$ 240.06M |
Currency in TWD
